Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antiproteases in the treatment of chronic pancreatitis.

Literature DB >> 17625311

Antiproteases in the treatment of chronic pancreatitis.

Yoshiharu Motoo¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2007 PMID： 17625311

Source DB: PubMed Journal: JOP ISSN： 1590-8577

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

1. An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice.

Authors: Jaroslaw Daniluk; Yan Liu; Defeng Deng; Jun Chu; Haojie Huang; Sebastian Gaiser; Zobeida Cruz-Monserrate; Huamin Wang; Baoan Ji; Craig D Logsdon
Journal: J Clin Invest Date: 2012-03-12 Impact factor: 14.808

2. A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste.

Authors: Geoffrey Chupp; Anne Spichler-Moffarah; Ole S Søgaard; Denise Esserman; James Dziura; Lisa Danzig; Reetika Chaurasia; Kailash P Patra; Aryeh Salovey; Angela Nunez; Jeanine May; Lauren Astorino; Amisha Patel; Stephanie Halene; Jianhui Wang; Pei Hui; Prashant Patel; Jing Lu; Fangyong Li; Geliang Gan; Stephen Parziale; Lily Katsovich; Gary V Desir; Joseph M Vinetz
Journal: medRxiv Date: 2022-01-31

Review 3. Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges.

Authors: Ismail Sami Mahmoud; Yazun Bashir Jarrar
Journal: Mol Biol Rep Date: 2021-05-22 Impact factor: 2.316

Review 4. TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections.

Authors: Li Wen Shen; Hui Juan Mao; Yan Ling Wu; Yoshimasa Tanaka; Wen Zhang
Journal: Biochimie Date: 2017-08-01 Impact factor: 4.079

5. Semi-Mechanistic Pharmacokinetic-Pharmacodynamic Model of Camostat Mesylate-Predicted Efficacy against SARS-CoV-2 in COVID-19.

Authors: Yuri Kosinsky; Kirill Peskov; Donald R Stanski; Diana Wetmore; Joseph Vinetz
Journal: Microbiol Spectr Date: 2022-04-12

Antiproteases in the treatment of chronic pancreatitis.

1. An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice.

2. A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste.

Review 3. Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges.

Review 4. TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections.

5. Semi-Mechanistic Pharmacokinetic-Pharmacodynamic Model of Camostat Mesylate-Predicted Efficacy against SARS-CoV-2 in COVID-19.

6. Overhauser-enhanced MRI of elastase activity from in vitro human neutrophil degranulation.

Review 7. Repurposing anticancer drugs for the management of COVID-19.

8. COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now-New Hopes?